OMRON Launches AI-Driven Medical Device Plan in Singapore for Chronic Disease Self-Management
OMRON Healthcare Singapore has partnered with insurance technology firm bolttech and insurer QBE to introduce a subscription plan for users of OMRON medical devices. This plan integrates AI-powered insights and health protection coverage, aiming to support individuals managing chronic conditions such as hypertension.
Subscribers using the OMRON connect mobile app receive monthly reports generated by AI algorithms. These reports provide clear summaries of blood pressure status and actionable recommendations for self-management. This approach encourages consistent monitoring and better cardiovascular health outcomes.
Alongside personalized insights, the plan includes health protection benefits from QBE with coverage of up to SG$10,000 (approximately $7,800) for heart attacks and strokes, plus accidental death benefits. The warranty has also been enhanced, covering device repairs due to accidental damage and battery issues.
Ronak Shah, CEO of QBE Singapore, explained that the program rewards users who regularly monitor their cardiovascular health. The goal is to promote healthier lifestyles that can extend life expectancy and reduce overall medical costs.
Coreline Soft and Siemens Healthineers Collaborate on AI Imaging Solutions
South Korean company Coreline Soft has partnered with Siemens Healthineers to integrate AI-based imaging analysis with diagnostic imaging equipment. Their collaboration focuses on developing AI algorithms utilizing photon-counting CT (PCCT) and positron emission tomography (PET) images.
These AI tools will undergo validation in hospital settings to ensure accuracy and clinical value. Moon Soo-ho, head of Siemens Healthineers’ Diagnostic Imaging Business Unit, highlighted the potential to improve diagnostic precision and streamline medical workflows through this partnership.
MedGenome Secures $48 Million to Expand Genomic Diagnostics in India
Indian genomics firm MedGenome raised $47.5 million in Series E funding led by Maj Invest. Established in 2013, MedGenome offers over 1,300 genetic tests with comprehensive multi-omics capabilities.
The company plans to use the new capital to broaden its genomic and integrated diagnostics services across India. CEO Dr. Vedam Ramprasad noted growing recognition of genomics' role in advancing healthcare innovation in the country.
This aligns with the Indian government’s recent initiatives, including the Indian Genomic Dataset and the Phenome India National Biobank. These efforts support large-scale genomic research and aim to sequence 10 million genomes to represent India’s diverse population.
Your membership also unlocks:
